Janux Therapeutics, Inc.
USD13.78
-0.63 (-4.37%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.21
Prev. Close
$14.41
Day Low
$13.78
Day High
$14.32
52W Low
$12.12
52W High
$35.34
Market Cap
$0.84B
Volume
0.68M
| 154,000 |
| $13.99 |
| 4 Feb 2026 | Go William | Chief Medical Officer | A-Award | Acquired | 44,000 | $0.00 |
| 4 Feb 2026 | Go William | — | Disposed | 0 | $0.00 |
| 2 Jan 2026 | Meyer Andrew Hollman | Chief Business Officer | S-Sale | Disposed | 1,879 | $13.73 |
| 2 Jan 2026 | DiRaimondo Thomas | Chief Scientific Officer | S-Sale | Disposed | 2,505 | $13.73 |
| 2 Jan 2026 | DiRaimondo Thomas | Chief Scientific Officer | A-Award | Acquired | 31,400 | $0.00 |
| 2 Jan 2026 | DiRaimondo Thomas | Chief Scientific Officer | A-Award | Acquired | 109,900 | $13.65 |
| 2 Jan 2026 | Campbell David Alan | director, officer: President and CEO | S-Sale | Disposed | 8,072 | $13.73 |
| 2 Jan 2026 | Campbell David Alan | director, officer: President and CEO | A-Award | Acquired | 96,600 | $0.00 |